Laborationshandledning · Korta peptider och kopparkomplex
What Is KPV? Alpha-MSH Fragment Peptide Research Overview
What is KPV? It is the tripeptide Lys-Pro-Val, the C-terminal fragment (residues 11-13) of alpha-melanocyte-stimulating hormone, studied in cell and mouse models of inflammation. This guide covers its structure, its origin in the melanocortin system, the PepT1 and NF-κB findings and the limits of the evidence.
Viktiga slutsatser
- KPV is Lys-Pro-Val, formula C16H30N4O4, molecular weight about 342.4 g/mol, the last three residues of the 13-residue hormone alpha-MSH.
- It lacks the His-Phe-Arg-Trp core that melanocortin receptors need for strong activation, so it is studied for inflammation rather than pigmentation.
- Dalmasso et al. (2008) reported that KPV enters intestinal and immune cells through the transporter PepT1 and inhibits NF-κB and MAP kinase signalling.
- Its evidence is preclinical (cells and mouse colitis models), and its mechanism is still debated.
Vad är ” KPV ”?
So, what is KPV? KPV is the tripeptide Lys-Pro-Val, corresponding to residues 11-13 at the C-terminus of alpha-MSH, the 13-residue neuropeptide cut from pro-opiomelanocortin (POMC). The foundational study by Dalmasso et al. (2008) describes it as possessing anti-inflammatory properties whose mechanism of action was unknown at the time.
Endast för forskningsändamål. Denna översikt sammanfattar publicerade resultat från laboratorie- och djurförsök. Baltic Peptides tillhandahåller denna förening för in vitro- och preklinisk forskning utförd av kvalificerade forskare; den är inte ett läkemedel och är inte avsedd för användning på människor eller djur.
Kemisk struktur och specifikationer
| Fastighet | Värde |
|---|---|
| Sekvens | H-Lys-Pro-Val-OH (KPV) |
| Längd | 3 residues |
| Molekylformel | C16H30N4O4 |
| Molekylvikt | 342.4 g/mol (average); 342.227 Da monoisotopic, calculated |
| CAS-nummer | 67727-97-3 (supplier-listed) |
| Ursprung | alpha-MSH residues 11-13 |
I confirmed that the sequence reproduces the formula and mass. KPV has no methionine, cysteine or tryptophan, so it is among the simpler peptides to handle. A tripeptide of this size is small enough that mass spectrometry cannot distinguish it from isomers such as Lys-Val-Pro, so identity also depends on sequencing or chromatography against a reference.
Upptäckt och forskningshistoria
The anti-inflammatory activity of alpha-MSH was traced to its C-terminal end. The tripeptide KPV was then tested as the smallest active fragment. Two 2008 papers reported anti-inflammatory activity in colitis models: Dalmasso et al. (2008) in Gastroenterology and a study of KPV in murine models of inflammatory bowel disease in Inflammatory Bowel Diseases.
A 2026 FDA briefing document for the Pharmacy Compounding Advisory Committee reviews the KPV literature, showing the compound has drawn regulatory attention as well as research interest (FDA).
Mechanism: PepT1 uptake and NF-κB inhibition
Transport into cells
Dalmasso et al. found that KPV is transported into cells by PepT1, a di- and tripeptide transporter normally expressed in the small intestine and induced in the colon during inflammatory bowel disease. At nanomolar concentrations KPV inhibited activation of NF-κB and MAP kinase signalling and reduced secretion of pro-inflammatory cytokines (PubMed).
An open mechanistic question
Some studies suggest MC1R involvement in other cell types, but in intestinal epithelium the effect has been shown to depend on PepT1 transport, a route that does not need a melanocortin receptor. KPV lacks the His-Phe-Arg-Trp core that melanocortin receptors use, so the mechanism remains an open question.
Huvudsakliga forskningsområden
- NF-κB and cytokine signalling: reduced activation and cytokine release in cultured cells.
- Intestinal inflammation models: DSS- and TNBS-induced colitis in mice.
- Skin and keratinocyte models: α-MSH-derived fragments in dermal inflammation studies.
- Melanocortin pharmacology: separating the anti-inflammatory activity of α-MSH from its pigmentary activity.
Vad publicerade studier faktiskt visar
| Bevistyp | Vad som rapporteras |
|---|---|
| Kemiska fakta | Sequence, formula and mass are straightforward and verifiable. |
| Cellstudier | PepT1-dependent uptake and inhibition of NF-κB and MAPK signalling at nanomolar concentrations. |
| Djurförsök | Reduced incidence of colitis indices in DSS- and TNBS-induced mouse models, with lower pro-inflammatory cytokine expression. |
| Forskning på människor | No completed registered clinical trials were found in the sources reviewed. |
Two mouse models of chemically induced colitis are a limited basis. They show an effect in those models, not in disease generally.
Vetenskapliga begränsningar och öppna frågor
- The evidence is preclinical, from cell lines and two mouse colitis models.
- The mechanism is debated, with PepT1 and possible melanocortin-receptor routes both proposed.
- A tripeptide has a short half-life and is likely to be degraded rapidly outside cells, which complicates interpretation.
- Independent replication beyond the early 2008 papers is limited in the sources reviewed.
Analytiska och laboratorierelaterade överväganden
Mass spectrometry should show the intact tripeptide at about 342.4 Da, and HPLC should separate sequence isomers and truncated products. Because KPV is short, hydrophilic and basic, it elutes early in reverse-phase methods and needs a suitable gradient or ion-pairing agent.
See how to store peptides and the guide to reading a peptide COA. Batch reports are on the COA page, and formats are on the KPV product page.
Källor och vidare läsning
- Dalmasso G. et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134(1):166-178. PubMed · PMC full text
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 14(3):324-331 (2008). PubMed
- FDA briefing document, Pharmacy Compounding Advisory Committee (2026). FDA
Alla produkter från Baltic Peptides levereras uteslutande för användning inom laboratorieforskning. De är varken läkemedel, kosttillskott eller livsmedel och är inte avsedda för användning på människor eller djur. Denna artikel sammanfattar publicerad forskning enbart i utbildningssyfte och beskriver inte någon användning på människor.
Vanliga frågor
Vanliga frågor
Vad är ” KPV ”?
What is the molecular weight and formula of KPV?
Does KPV act on melanocortin receptors like alpha-MSH?
What is PepT1 and why does it matter for KPV?
What did the 2008 colitis studies show?
Is there human clinical evidence for KPV?
Kan ” KPV ” orsaka pigmentförändringar?
Läs vidare
Relaterad läsning
KPV
Current batches, formats and the COA for KPV.
Vad är Melanotan II?
A full cyclic melanocortin agonist, for contrast with KPV.
En förklaring av peptidblandningar
Varför komponentforskningen inte fastställer en sammansatt formulering.
Research-grade KPV, tested before it ships
Oberoende analysresultat från HPLC och masspektrometri för varje sats som levereras från EU.
